Sunday April 26, 2015   
Find us Facebook Follow us on Twitter Watch us on YouTube    
Donate Now
Research Grants


Treating Brain Tumors with lnterlaced Carbon Microbeams
Led by F. Avraham Dilmanian, Ph.D. at Brookhaven National Laboratory

The Robert Silverman Memorial Grant

Dr. Dilmanian’s research shows promise in its exploration of the ability to use “slices” of these radiation beams from different directions that allow the point of radiation treatment to become “focused” on the area of the brain tumor without being destructive along the way in. Additionally, this type of treatment may actually promote the growth of healthy tissue surrounding the brain tumor at the same time, by increasing the blood supply of the healthy tissue, and allow for expedited healing.

This type of treatment may also be of value in patients with tumors that are unapproachable from a surgical perspective, which would hold promise for patients who were previously thought to be inoperable, and either suffer the consequences of destructive forms of radiation, or an even worse fate.


The research team at the NASA Space Radiation Laboratory in the Broohaven National Laboratory. Pictured, from left to right, Jane Park (lead student), Peggy Micca and Michael Makar (medical technicians), Joseph Gatz (technician), Adam Rusek (NSRL’s manager and chief collaborator), and F. Avraham Dilmanian (lead researcher.)



October, 2009

Dr. Dilmanian’s laboratory developed a process for injecting brain tumor cells into rabbits’ brains to produce consistent and measurable results. Through experimentation, they are developing a program for dose distribution in tissues from interlaced carbon microbeams. Finally, the team learned that the conventional microbeam set-up did not work for their particular study and have altered the process in order to test their treatment method.

Click here for a full list of research grants funded by Voices Against Brain Cancer.


Voices Against Brain Cancer is a not-for-profit public charity recognized by the IRS under 501 (c) (3)